Lecigon

Entacapone, Levodopa and Carbidopa, the active ingredients in Lecigon, are a COMT inhibitor/DOPA decarboxylase inhibitor combination presented as a tablet for intestinal use. It treats Parkinson's disease in adult patients by improving motor control and reducing fluctuations.

GNH USA supplies Lecigon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lecigon is used in the management of Parkinsonian disorders, targeting dopamine deficiency and motor fluctuations. - Parkinson's disease (early stage): improves motor symptoms and reduces rigidity. - Parkinson's disease (advanced stage): helps maintain functional mobility and lessens "off" periods. - Parkinsonian motor fluctuations: smooths daily dopamine levels to decrease unpredictable symptom swings.

Lecigon may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness or light‑headedness: often related to orthostatic changes. - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed intestinal motility. - Hallucinations: visual or auditory disturbances, especially in older adults. - Dyskinesia: involuntary movements linked to levodopa exposure.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe liver injury: elevated transaminases requiring monitoring. - Hyperpyrexia: unexplained high fever with muscle rigidity. - Severe hypotension: marked drop in blood pressure causing fainting. - Allergic reactions: rash, angioedema, or anaphylaxis. - Suicidal ideation: rare mood changes needing immediate attention.

Before initiating Lecigon, clinicians should consider several safety measures. - Monitor blood pressure: watch for orthostatic hypotension, especially at treatment start. - Assess liver function: periodic tests are advised due to entacapone metabolism. - Evaluate for dyskinesia: adjust levodopa dose if excessive movements appear. - Avoid abrupt discontinuation: sudden stop may worsen Parkinsonism. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Lecigon can interact with other medicines, requiring careful review.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may increase confusion and cognitive decline. - CNS depressants: additive sedation and impaired coordination.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: may enhance hypotensive effects. - SSRIs or SNRIs: monitor for serotonin syndrome signs. - Iron or calcium supplements: can reduce levodopa absorption; separate dosing times.